A recent study using a Monte Carlo computer simulation model demonstrated 6-month ALT and 12-month HCV antibody testing a cost-effective screening strategy for AHC among HIV-infected MSM when the HIV incidence was ≤1.25 cases/100 person-years [56]. The gene discussed is GPT; the disease is alternating hemiplegia of childhood.